Hemorrheologic changes induced by aqueous extract of Ligaria cuneifolia: Treatment by two different administration routes

Clinical Hemorheology and Microcirculation

Volumn 31, Issue 2, 2004, Pages 113-121

  Dominighini, Alicia ^a   Ferrero, Mariana ^a   Mengarelli, Guillermo ^a   Ronco, María Teresa ^c   Alvarez, María De Luján ^c   Wagner, Marcelo ^b   Gurni, Alberto ^b   Carnovale, Cristina ^c   Luquita, Alejandra ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIGARIA CUNEIFOLIA EXTRACT; PLANT EXTRACT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; ERYTHROCYTE DEFORMABILITY; LIGARIA CUNEIFOLIA; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEDICINAL PLANT; NONHUMAN; RAT; TRADITIONAL MEDICINE;

ANIMALS; ARGENTINA; BILE; BILE ACIDS AND SALTS; BLOOD VISCOSITY; CHOLAGOGUES AND CHOLERETICS; CHOLESTEROL; DRUG EVALUATION, PRECLINICAL; ERYTHROCYTE INDICES; ERYTHROCYTES; HEMORHEOLOGY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LIVER; LORANTHACEAE; MALE; MEDICINE, TRADITIONAL; PLANT EXTRACTS; RATS; RATS, WISTAR; WATER;

EID: 4644287783     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. B.A. Barlow, Classification of Loranthaceae and Viscaceae, Proceedings ofLinnean Society of New South Wales 89 (1964), 268-272.
2. J. Kujit, Monograph of the Eremolepidaceae, Systematic Botany Monographs 18 (1988), 1-60.
3. B.G. Varela and A.A. Gurni, Anatomía foliar y caulinar comparativa del muérdago criollo y del muérdago europeo, Acta Farmacéutica Bonaerense 14(1) (1995), 21-29.
4. M. Wagner, T. Fernández, B. Varela, E. Alvarez, R. Ricco, S. Hajos and A. Gurni, Anatomical, phitochemical and immunochemical studies on Ligaria cuneifolia (R. et P.) Tiegh (Lorantaceae), Pharmaceutical Biology 36(2) (1998), 1-9.
5. T. Fernández, M. Wagner, B.G. Varela, R.A. Ricco, S.E. Hajos, A.A. Gurni and E. Alvarez, Study of an Argentine Mistletoe, the hemiparasite Ligaria cuneifolia (R. et P.) Tiegh. (Lorantaceae), Journal of Ethnopharmacology 62 (1998), 25-34.
6. E.L. Ratera and M.O. Ratera, Plantas de la Flora Argentina empleadas en Medicina Popular, Hemisferio Sur ed., Buenos Aires, 1980, pp. 823-835.
7. C.A. Taira, M.L. Wagner, H.M. Adrados, R. Piño and A.A. Gurni, Estudio Farmacológico de un Agente Vasoactivo presente en Ligaria cuneifolia var. Cuneifolia, Acta Farmacéutica Bonaerense 13(2) (1994), 91-95.
8. G. Mengarelli, A. Dominighini, M. Ferrero, M.L. Alvarez, M. Wagner, A. Gurni, C.E. Carnovale and A. Luquita, Evaluation of hemorrheological parameteres and biliary secretion in Ligaria cuneifolia (Argentine mistletoe) extract treated rats, Pharmaceutical Biology 39(6) (2001), 435-439.
9. S. Chien, Hemorheology in clinical medicine, Clin. Hemorheol. 2 (1982), 137-142.
10. W. Jakoby, J. Bend and J. Caldwell, Introduction, in: Metabolic Basis of Detoxication, W Jakoby, J. Bend and J. Caldwell, eds, Academic Press, New York, 1982, pp. 1-3.
11. J. Woher, H. Liehr and M. Grün, Hepatic clearance of endotoxins: Differences in arterial and portal venous infusion, J. Reticuloendothel. Soc. 23 (1978), 145-152.
12. 32 chromium phosphate colloid uptake in the isolated perfused liver preparation, Am. J. Physiol. 184 (1956), 593-598.
13. D. Abbiatti, Las Lorantáceas Argentinas, Revista del Museo de La Plata (nueva botánica) 7 (1946), 1-110.
14. R.J. Roberts, C.D. Klaassen and G.L. Plaa, Maximun biliary excretion of bilirubin and sulfobromophtalein during anaesthesia-induced alteration of rectal temperature, Proc. Soc. Exp. Biol. Med. 125 (1967), 313-316.
15. R.J. Henry, D.S. Cannon and J.W. Winkelmann, Clinical Chemistry Principles and Techniques, Harper & Row, 1974, pp. 1440-1449.
16. International Committee for Standardization in Hematology, Expert panel on blood rheology. Guidelines for measurement of blood viscosity and erythrocyte deformability, Clin. Hemorheol. 6 (1986), 439-453.
17. B. Chailley, F. Giraud and M. Claret, Alteration in human erythrocyte shape and the state of spectrin and phospholipid phosphorilation induced by cholesterol depletion, Biochem. Biophys. Acta 643 (1981), 636-641.
18. H.L. Reid, A.J. Barnes, P.J. Lock, J.A. Dormandy and T.L. Dormandez, A simple method for measuring erythocyte deformability, J. Clin. Pathol. 29 (1976), 855-858.
19. P. Talalay, Enzymatic analysis of steroid hormones, Meth. Biochem. Anal. 8 (1960), 119-143.
20. P. Berthelot, S. Erlinger, D. Dhumeaux and A.M. Preaux, Mechanism of phenobarbital induced hypercholeresis in the rat, Am. J. Physiol. 819 (1970), 809-813.
21. O.H. Lowry, N.J. Rosebrough, A.L. Fair and R.J. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193 (1951), 265-275.
22. J.P. Fawcett and D.B. Menkes, Does cholesterol depletion have adverse effects on blood rheology? Angiology 45(3) (1994), 199-206.
23. T. Shiga, N. Maeda, T Suda, K. Kon and M. Sekiva, Influences of cholesterol on red cell defdormability, Clin. Hemorheol. 2 (1982), 77-83.
24. A. Vaya, M. Martinez, M. Guillen, J. Dalmau and J. Aznar, Erythrocyte deformability in young familial hypercholesterolemia, Clin. Hemorheol. Microcirc. 19 (1998), 43-48.
25. J.F. Stoltz, S. Gaillard, D. Rouselle, P. Voisin and P. Drouin, Rheological study of blood during primary hyoperlipoproteinemia, Clin. Hemorheol. 1 (1981), 227-232.
26. A. Vaya, M. Martinez, R. Carmena and J. Aznar, The lipid composition of red blood cells and their hemorheological behavior in patients with primary hyperlipoproteinemia, Clin. Hemorheol. 13 (1993), 447-457.
27. G.D.O. Lowe, M.M. Drummond, P. Stromberg, A.R. Lorimer and C.D. Forbes, Determinants of blood rheology in type II hyperlipoproteinemias, Scand. Clin. Lab. Invest. 41 (1981), 263-267.
28. V. Eijzenbach, P.A.M.M. Aarts, J. Gevers Leuven and H. Goslinga, Rheological profile of patients with hypercholesterolemia and hypertriglyceridemia, Clin. Hemorheol. 9 (1989), 463-468.
29. H.G. Roggenkamp, F. Jung, H.P. Nüttgens, H. Kiesewetter, E.B. Ringelstein and R. Schneider, Erythrocyte rigidity in healthy patients with cardiovascular disease risk factors, Klin. Wochenschr. 64 (1986), 1091-1096.
30. A. Chabanel, M. Flamm and K.L.P. Sung, Influence of cholesterol content on red cell membrane viscoelasticity and fluidity, Biophys. J. 44 (1983), 171-176.
31. D.W. Russel, Cholesterol biosynthesis and metabolism, Cardiovasc. Drugs Ther. 6 (1992), 103-110.
32. I. Björkhem, in: Sterols and Bile Acids. Mechanism of Bile Acid Synthesis in Mammalian Liver, H. Danielsson and J. Sjövall, eds, Elsevier Scientific Publishers, Amsterdam, 1985, pp. 231-236.
33. Z.R. Vlahcevic, W.M. Pandak, D.M. Heuman and P.B. Hylemon, Function and regulation of hydrolases involved in the bile acid biosynthesis pathways, Semin. Liver Dis. 12 (1992), 403-419.
34. S.D. Turley and J.M. Dietschy, in: The Liver, Biology and Pathobiology, I. Arias, H. Popper and D. Schachter, eds, Raven Press, New York, 1982, pp. 467-474.
35. M.J. Telen, The mature erythrocyte, Section 2: The erythrocyte, in: Wintrobe's Clinical Hematology (1), G.R. Lee, T.C. Bithell, J. Foerster, J.W. Athens and J.N. Lukens, eds, 9th edn, Lea and Febiger, Philadelphia, 1993, pp. 101-133.
36. A. Luquita, A.M. Gennaro and M. Rasia, Effects of subnormal hemoglobin concentration on the deformability of normocytic erythrocytes, Clin. Hemorheol. 16(2) (1996), 117-127.